Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 21 studies | 43% ± 18% | |
| endothelial cell | 19 studies | 33% ± 12% | |
| oligodendrocyte | 17 studies | 49% ± 18% | |
| oligodendrocyte precursor cell | 14 studies | 31% ± 13% | |
| macrophage | 13 studies | 31% ± 13% | |
| fibroblast | 13 studies | 34% ± 13% | |
| microglial cell | 12 studies | 34% ± 12% | |
| GABAergic neuron | 11 studies | 46% ± 23% | |
| glutamatergic neuron | 11 studies | 54% ± 24% | |
| B cell | 11 studies | 21% ± 7% | |
| adipocyte | 9 studies | 54% ± 12% | |
| smooth muscle cell | 9 studies | 28% ± 9% | |
| pericyte | 8 studies | 28% ± 10% | |
| ciliated cell | 8 studies | 30% ± 9% | |
| neuron | 7 studies | 42% ± 23% | |
| retinal ganglion cell | 7 studies | 59% ± 25% | |
| dendritic cell | 7 studies | 22% ± 8% | |
| mast cell | 7 studies | 25% ± 9% | |
| interneuron | 6 studies | 51% ± 24% | |
| epithelial cell | 6 studies | 42% ± 17% | |
| retina horizontal cell | 6 studies | 39% ± 12% | |
| retinal cone cell | 6 studies | 46% ± 14% | |
| Mueller cell | 6 studies | 39% ± 8% | |
| endothelial cell of lymphatic vessel | 6 studies | 28% ± 8% | |
| type I pneumocyte | 6 studies | 29% ± 5% | |
| type II pneumocyte | 6 studies | 29% ± 5% | |
| amacrine cell | 5 studies | 40% ± 9% | |
| retinal rod cell | 5 studies | 45% ± 13% | |
| cardiac muscle cell | 5 studies | 60% ± 14% | |
| myeloid cell | 5 studies | 25% ± 7% | |
| T cell | 5 studies | 25% ± 6% | |
| club cell | 5 studies | 27% ± 10% | |
| basal cell | 5 studies | 37% ± 18% | |
| granule cell | 4 studies | 38% ± 13% | |
| retinal pigment epithelial cell | 4 studies | 42% ± 21% | |
| CD4-positive, alpha-beta T cell | 4 studies | 20% ± 4% | |
| CD8-positive, alpha-beta T cell | 4 studies | 18% ± 5% | |
| alveolar macrophage | 4 studies | 30% ± 10% | |
| natural killer cell | 4 studies | 23% ± 5% | |
| plasmacytoid dendritic cell | 4 studies | 25% ± 6% | |
| conventional dendritic cell | 3 studies | 27% ± 7% | |
| GABAergic interneuron | 3 studies | 38% ± 8% | |
| glial cell | 3 studies | 26% ± 6% | |
| plasma cell | 3 studies | 29% ± 6% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 21% ± 6% | |
| retinal bipolar neuron | 3 studies | 29% ± 6% | |
| mononuclear phagocyte | 3 studies | 20% ± 2% | |
| GABAergic amacrine cell | 3 studies | 37% ± 4% | |
| OFF-bipolar cell | 3 studies | 48% ± 26% | |
| ON-bipolar cell | 3 studies | 51% ± 23% | |
| glycinergic amacrine cell | 3 studies | 33% ± 2% | |
| myofibroblast cell | 3 studies | 29% ± 9% | |
| hepatocyte | 3 studies | 56% ± 15% | |
| muscle cell | 3 studies | 48% ± 20% | |
| abnormal cell | 3 studies | 34% ± 14% | |
| ependymal cell | 3 studies | 51% ± 20% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 23% ± 9% | |
| monocyte | 3 studies | 30% ± 9% | |
| respiratory goblet cell | 3 studies | 36% ± 15% | |
| lymphocyte | 3 studies | 34% ± 11% | |
| mesothelial cell | 3 studies | 32% ± 9% | |
| mucus secreting cell | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2422.24 | 2642 / 2642 | 100% | 28.17 | 705 / 705 |
| adrenal gland | 100% | 1588.74 | 258 / 258 | 100% | 20.77 | 229 / 230 |
| prostate | 99% | 650.00 | 242 / 245 | 100% | 11.42 | 502 / 502 |
| breast | 100% | 663.18 | 457 / 459 | 99% | 7.20 | 1109 / 1118 |
| thymus | 99% | 603.85 | 645 / 653 | 100% | 9.37 | 603 / 605 |
| bladder | 100% | 575.71 | 21 / 21 | 98% | 6.34 | 495 / 504 |
| uterus | 98% | 479.07 | 166 / 170 | 98% | 6.42 | 452 / 459 |
| liver | 96% | 536.13 | 217 / 226 | 100% | 6.62 | 405 / 406 |
| kidney | 94% | 524.74 | 84 / 89 | 99% | 6.13 | 895 / 901 |
| ovary | 93% | 402.35 | 167 / 180 | 100% | 9.67 | 430 / 430 |
| esophagus | 94% | 496.29 | 1355 / 1445 | 97% | 4.87 | 178 / 183 |
| lung | 93% | 449.31 | 535 / 578 | 98% | 5.54 | 1136 / 1155 |
| intestine | 92% | 468.73 | 887 / 966 | 98% | 4.80 | 516 / 527 |
| stomach | 87% | 395.59 | 314 / 359 | 98% | 4.45 | 280 / 286 |
| skin | 87% | 346.32 | 1565 / 1809 | 94% | 5.04 | 443 / 472 |
| pancreas | 65% | 230.59 | 214 / 328 | 100% | 5.73 | 178 / 178 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.93 | 29 / 29 |
| muscle | 100% | 3423.89 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 533.25 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.82 | 1 / 1 |
| adipose | 99% | 683.90 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 679.95 | 1318 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 1327.01 | 825 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 4.56 | 42 / 45 |
| eye | 0% | 0 | 0 / 0 | 89% | 4.92 | 71 / 80 |
| peripheral blood | 19% | 69.90 | 179 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006796 | Biological process | phosphate-containing compound metabolic process |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003998 | Molecular function | acylphosphatase activity |
| Gene name | ACYP2 |
| Protein name | Acylphosphatase-2 (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2) Acylphosphatase (EC 3.6.1.7) Acylphosphatase 2 Acylphosphatase-2 (EC 3.6.1.7) (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2) acylphosphatase (EC 3.6.1.7) Acylphosphatase, muscle type isozyme Acylphosphatase 2 (HCG2040114, isoform CRA_a) |
| Synonyms | hCG_2040114 ACYP |
| Description | FUNCTION: Its physiological role is not yet clear. |
| Accessions | ENST00000394666.8 ENST00000606865.1 ENST00000406041.5 U3KQ09 Q53TK7 ENST00000494922.6 U3KPX1 U3KPX8 U3KQL2 P14621 ENST00000606082.5 U3KQ94 ENST00000303536.8 F8WA34 ENST00000422521.2 E9PF46 Q4ZFV7 ENST00000607452.6 |